Abbott Laboratories ABT:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD

After Hours: Last | 4:05 PM EDT

104.87UNCH (UNCH)

Volume

676,561

104.87

+0.28 (+0.27%)

Volume

7,225,935

52 week range

89.67 - 121.64

Open104.45
Day High105.19
Day Low104.16
Prev Close104.59
52 Week High121.64
52 Week High Date03/08/24
52 Week Low89.67
52 Week Low Date10/12/23

Key Stats

Market Cap182.435B
Shares Out1.74B
10 Day Average Volume5.51M
Dividend2.20
Dividend Yield2.10%
Beta0.74
YTD % Change-4.72

KEY STATS

Open104.45
Day High105.19
Day Low104.16
Prev Close104.59
52 Week High121.64
52 Week High Date03/08/24
52 Week Low89.67
52 Week Low Date10/12/23
Market Cap182.435B
Shares Out1.74B
10 Day Average Volume5.51M
Dividend2.20
Dividend Yield2.10%
Beta0.74
YTD % Change-4.72

RATIOS/PROFITABILITY

EPS (TTM)3.22
P/E (TTM)32.57
Fwd P/E (NTM)22.83
EBITDA (TTM)9.841B
ROE (TTM)14.85%
Revenue (TTM)40.326B
Gross Margin (TTM)55.25%
Net Margin (TTM)13.96%
Debt To Equity (MRQ)37.58%

EVENTS

Earnings Date07/18/2024(est)
Ex Div Date04/12/2024
Div Amount0.55
Split Date-
Split Factor-

Latest On Abbott Laboratories

PEG ratio can help inform stock buying decisions. What it is and how to use itMay 12, 2024CNBC.com
Here's why we scooped up additional shares of these 2 lagging health-care stocksMay 9, 2024CNBC.com
Thursday, May 9, 2024: Cramer calls this grocery stock 'consistent' after its monthly sales reportMay 9, 2024CNBC.com
TRADE ALERTWe're exiting a troubled drugmaker and buying 2 stocks with brighter outlooksMay 8, 2024CNBC.com
Jim Cramer's favorite investment themes in tough markets and 3 stocks he likes nowApril 25, 2024CNBC.com

Content From Our Affiliates

Buy Recommendation for Abbott Laboratories Backed by Strong Sales Growth and Promising Pipeline12 Hours AgoTipRanks
FDA posts Class I recall of Abbott HeartMate 3 LVAS implant kitMay 15, 2024TipRanks
Evercore ISI removes several healthcare names from ‘Tactical Outperform’ listMay 6, 2024TipRanks
Analysts Are Bullish on Top Healthcare Stocks: Abbott Labs (ABT), Iterum Therapeutics (ITRM)April 30, 2024TipRanks
Abbott’s dissolving stent receives FDA approval for arteries below the kneeApril 29, 2024TipRanks

Profile

Abbott Laboratories is a global healthcare company. The Company is engaged in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. The...

Robert Ford

Chairman of the Board, Chief Executive Officer

Philip Boudreau

Chief Financial Officer, Senior Vice President - Finance

Louis Morrone

Executive Vice President - Core Diagnostics

Daniel Salvadori

Executive Vice President, Group President - Established Pharmaceuticals and Nutritional Products

Hubert Allen

Executive Vice President, General Counsel, Secretary

Address

100 Abbott Park Road, Abbot Park

Abbott Park, IL

60064-3500

United States

https://www.abbott.com

Top Peers

SYMBOL	LAST	CHG	%CHG
TMO Thermo Fisher Scientific Inc	597.15	-1.87	-0.31%
DHR Danaher Corp	264.84	+1.38	+0.52%
MDT Medtronic PLC	85.64	+0.92	+1.09%
SYK Stryker Corp	333.98	+1.99	+0.60%
BSX Boston Scientific Corp	74.55	+0.10	+0.13%